A collective european vision and NutriEV´s place within it
From a single idea to a shared mission
What if food could speak?
Not metaphorically but biologically.
What if what we eat carries structured molecular messages that travel through our bodies, influence our metabolism, interact with our microbiome, and even leave measurable traces in our sweat?
This is the kind of question driving the EIC Pathfinder Precision Nutrition Portfolio, a bold European initiative designed to rethink the relationship between diet and health. And at the heart of this shared vision stands NutriEV.
Europe’s Precision Nutrition strategy: Thinking bigger
In 2023, the European Innovation Council launched a Pathfinder Challenge dedicated to Precision Nutrition. The aim was ambitious: to move beyond generic dietary advice and investigate the deep biological mechanisms linking diet, the gut microbiome and glycans to obesity, diabetes and other non-communicable diseases.
But instead of funding isolated projects working in parallel, the EIC chose a different model.
Eight pioneering projects were brought together into a Precision Nutrition Portfolio, not just a funding cluster, but a coordinated ecosystem.
Together, these projects explore complementary angles of the same grand challenge. BUGS4URATE investigates probiotic and dietary strategies to prevent hyperuricaemia and gout. FIBRE-MATCH develops microbiota-matched fibre interventions to improve metabolic health. INTERACTHOMIG examines host-microbiome-glycan interactions, the so-called “triangle of sweetness.” MENTORING addresses malnutrition and metabolic health through precision nutrition frameworks. NUTRIMMUNE focuses on optimising immune responses for metabolic resilience. GLUCOTYPES studies glucose variability patterns for personalised diabetes management. And DIBAN explores novel foods to tackle type 2 diabetes by linking intestinal bacteria and host metabolism.
Each project brings a distinct expertise. Together, they form a strategic European effort to decode nutrition at biological resolution.
NutriEV: Bringing vesicles into the nutrition debate
Within this European landscape, NutriEV introduces something radically new.
While our sister projects focus on fibre strategies, immune biomarkers, glucose dynamics or microbiome modulation, NutriEV asks a different question:
What if nutrition-derived extracellular vesicles, tiny, naturally occurring biological particles found in raw and fermented foods are key actors in metabolic regulation?
These nutriEVs are not just fragments. They are structured, membrane-bound carriers transporting proteins, lipids, RNA and with glycans attached to their surface molecules.
- They survive digestion.
- They interact with gut cells.
- They may cross biological barriers.
And potentially, they influence systemic metabolism.
In a portfolio dedicated to understanding how diet interacts with biology, NutriEV adds a vesicle-mediated dimension to the conversation.
A living collaboration
The Precision Nutrition Portfolio is organised around four operational pillars:
- Technological synergies
- Regulatory and clinical trial alignment
- Business development
- Communication and dissemination
NutriEV actively contributes to each of them.
Technological synergies
The portfolio’s technological working group aims to combine expertise in microbiome science, bioinformatics, carbohydrate chemistry, in vitro modelling and biosensors.
NutriEV contributes:
- Advanced glycoproteomics to decode vesicle surface glycans
- Organ-on-chip models mimicking gut and skin tissues
- In vivo obesity and inflammation models
- Labelled nutriEV systems to track biological distribution
- Sweat-based EV detection concepts
Where other projects investigate fibre–immune interactions or glucose variability patterns, NutriEV expands the biological toolkit by integrating vesicle-based signalling into precision nutrition research.
Regulatory and clinical integration
Precision nutrition must be scientifically robust and ethically grounded.
The portfolio emphasises harmonisation of clinical approaches, biomarker frameworks and regulatory readiness.
NutriEV supports this ambition through:
- Human cohort studies in obese and lean individuals
- Dietary intervention trials with nutriEV-rich foods
- Multi-omics profiling across stool, saliva, urine and sweat
- Exploration of vesicle-based biomarkers
This ensures that vesicle science moves beyond laboratory discovery towards clinical relevance.
Business and innovation pathways
The portfolio explicitly seeks to create a new generation of European companies at the forefront of personalised nutrition.
NutriEV’s innovation pathways align strongly with this objective:
- NutriEV-based superfood concepts
- Glycan-informed metabolic diagnostics
- Non-invasive sweat biosensors for dietary monitoring
By adding vesicle analytics to the portfolio’s innovation landscape, NutriEV strengthens the bridge between molecular research and market-ready solutions.
Why this matters
Obesity rates have nearly tripled since 1975. Type 2 diabetes and metabolic disorders continue to rise. Dietary guidelines remain largely generalised.
The Precision Nutrition Portfolio seeks to challenge this status quo by grounding nutrition in biology.
NutriEV strengthens this strategy by introducing the possibility that:
Food does not merely provide nutrients.
It may deliver structured biological information.
If nutriEVs prove capable of modulating metabolic pathways and being detected non-invasively, we may be looking at:
- New preventive strategies
- Personalised dietary monitoring
- Novel therapeutic avenues
- And a redefinition of what “functional food” truly means
Beyond individual projects
The Portfolio Strategic Plan clearly states that its value lies in collaboration and shared ambition.
NutriEV is proud to contribute a vesicle-based perspective to this collective European effort, helping to shape a future where nutrition is not generic, but precise, measurable and biologically informed.